Works matching IS 13518216 AND DT 2016 AND VI 22 AND IP 5

Results: 57

Editorial Board.

Published in:: Haemophilia, 2016, v. 22, n. 5, p. 635, doi. 10.1111/hae.12824
Publication type:: Article

Table of Contents.

Published in:: Haemophilia, 2016, v. 22, n. 5, p. 637, doi. 10.1111/hae.12825
Publication type:: Article

Instructions for Authors.

Published in:: Haemophilia, 2016, v. 22, n. 5, p. 814, doi. 10.1111/hae.12826
Publication type:: Article

Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e427, doi. 10.1111/hae.12924

By:

Lyu, C.;
Xue, F.;
Liu, X.;
Liu, W.;
Fu, R.;
Sun, T.;
Wu, R.;
Zhang, L.;
Li, H.;
Zhang, D.;
Yang, R.

Publication type:

Article

Potential biomarkers of haemophilic arthropathy: correlations with compatible additive magnetic resonance imaging scores.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 760, doi. 10.1111/hae.12936

By:

Oldenburg, J.;
Zimmermann, R.;
Katsarou, O.;
Zanon, E.;
Kellermann, E.;
Lundin, B.;
Ellinghaus, P.

Publication type:

Article

Prospective evaluation of treatment regimens, efficacy and safety of a recombinant factor VIII concentrate in haemophilia A: the German EffeKt study.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 684, doi. 10.1111/hae.12941

By:

Klamroth, R.;
Miesbach, W.;
Staritz, P.

Publication type:

Article

Optimization of the thrombin generation test components to measure potency of factor VIII concentrates.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 780, doi. 10.1111/hae.12943

By:

Jha, N. K.;
Shestopal, S. A.;
Gourley, M. J.;
Woodle, S. A.;
Liang, Y.;
Sarafanov, A. G.;
Weinstein, M.;
Ovanesov, M. V.

Publication type:

Article

Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 692, doi. 10.1111/hae.12947

By:

Santagostino, E.;
Pol, S.;
Olveira, A.;
Reesink, H. W.;
Erpecum, K.;
Bogomolov, P.;
Xu, D.;
Critelli, L.;
Srinivasan, S.;
Cooney, E.

Publication type:

Article

Lupus anticoagulants associated inhibitor against factor IX in a young patient with haemophilia B.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e437, doi. 10.1111/hae.12956

By:

Barnbrock, A.;
Heller, C.;
Königs, C.;
Budde, U.;
Schwabe, D.

Publication type:

Article

Haemarthrosis model in mice: BSS - Bleeding Severity Score assessment system.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 790, doi. 10.1111/hae.12950

By:

Hakobyan, N.;
Valentino, L. A.;
Cong, L.;
Enockson, C.;
Song, X. Q.;
Desai, S.;
Radtke, R.;
Fogg, L. F.

Publication type:

Article

Efficacy and safety of BAY 81-8973, a full-length recombinant factor VIII: results from the LEOPOLD I trial.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 706, doi. 10.1111/hae.12952

By:

Saxena, K.;
Lalezari, S.;
Oldenburg, J.;
Tseneklidou ‐ Stoeter, D.;
Beckmann, H.;
Yoon, M.;
Maas Enriquez, M.

Publication type:

Article

Experience of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency undergoing surgery.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 713, doi. 10.1111/hae.12954

By:

Escobar, M. A.;
Auerswald, G.;
Austin, S.;
Huang, J. N.;
Norton, M.;
Millar, C. M.

Publication type:

Article

Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 739, doi. 10.1111/hae.12955

By:

Windyga, J.;
Dolan, G.;
Altisent, C.;
Katsarou, O.;
López Fernández, M. ‐ F.;
Zülfikar, B.

Publication type:

Article

Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 700, doi. 10.1111/hae.12949

By:

Mason, J. A.;
Robertson, J. D.;
McCosker, J.;
Williams, B. A.;
Brown, S. A.

Publication type:

Article

RCT of a 6-month programmed sports therapy ( PST) in patients with haemophilia - Improvement of physical fitness.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 765, doi. 10.1111/hae.12957

By:

Runkel, B.;
Czepa, D.;
Hilberg, T.

Publication type:

Article

Circulating FVIII-specific IgG, IgA and IgM memory B cells from haemophilia A patients.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 799, doi. 10.1111/hae.12958

By:

Diaz, I.;
Bolloré, K.;
Tuaillon, E.;
Lapalud, P.;
Giansily ‐ Blaizot, M.;
Vendrell, J. P.;
Schved, J. F.;
Lavigne ‐ Lissalde, G.

Publication type:

Article

Genotyping might help therapeutic decision-making in patients with von Willebrand disease type 2 B.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e439, doi. 10.1111/hae.12960

By:

Rugeri, L.;
Fretigny, M.;
Dargaud, Y.;
Nougier, C.;
Vinciguerra, C.

Publication type:

Article

Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 806, doi. 10.1111/hae.12962

By:

Kitchen, S.;
Jennings, I.;
Makris, M.;
Kitchen, D. P.;
Woods, T. A. L.;
Walker, I. D.

Publication type:

Article

Can the phenotype of inherited fibrinogen disorders be predicted?

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 667, doi. 10.1111/hae.12967

By:

Casini, A.;
Moerloose, P.

Publication type:

Article

Population pharmacokinetic modelling of factor IX activity after administration of recombinant factor IX in patients with haemophilia B.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e359, doi. 10.1111/hae.12969

By:

Suzuki, A.;
Tomono, Y.;
Korth ‐ Bradley, J. M.

Publication type:

Article

The evolution of comprehensive haemophilia care in the United States: perspectives from the frontline.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 676, doi. 10.1111/hae.12970

By:

Aledort, L. M.

Publication type:

Article

Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 721, doi. 10.1111/hae.12974

By:

Vepsäläinen, K.;
Lassila, R.;
Arola, M.;
Huttunen, P.;
Koskinen, S.;
Ljung, R.;
Lähteenmäki, P.;
Möttönen, M.;
Riikonen, P.

Publication type:

Article

Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 752, doi. 10.1111/hae.12978

By:

Napolitano, M.;
Di Minno, M. N. D.;
Batorova, A.;
Dolce, A.;
Giansily ‐ Blaizot, M.;
Ingerslev, J.;
Schved, J. ‐ F.;
Auerswald, G.;
Kenet, G.;
Karimi, M.;
Shamsi, T.;
Ruiz de Sáez, A.;
Dolatkhah, R.;
Chuansumrit, A.;
Bertrand, M. A.;
Mariani, G.

Publication type:

Article

First trimester prenatal diagnosis of severe FXIII deficiency.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e443, doi. 10.1111/hae.12982

By:

Shanbhag, S.;
Ghosh, K.;
Shetty, S.

Publication type:

Article

Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 730, doi. 10.1111/hae.12985

By:

Klamroth, R.;
Simpson, M.;
Depka ‐ Prondzinski, M.;
Gill, J. C.;
Morfini, M.;
Powell, J. S.;
Santagostino, E.;
Davis, J.;
Huth ‐ Kühne, A.;
Leissinger, C.;
Neumeister, P.;
Bensen ‐ Kennedy, D.;
Feussner, A.;
Limsakun, T.;
Zhou, M.;
Veldman, A.;
St. Ledger, K.;
Blackman, N.;
Pabinger, I.

Publication type:

Article

Interim results from a large multinational extension trial (guardian™2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e445, doi. 10.1111/hae.12990

By:

Lentz, S. R.;
Cerqueira, M.;
Janic, D.;
Kempton, C.;
Matytsina, I.;
Misgav, M.;
Oldenburg, J.;
Ozelo, M.;
Recht, M.;
Rosholm, A.;
Savic, A.;
Suzuki, T.;
Tiede, A.;
Santagostino, E.

Publication type:

Article

Acquired haemophilia A in a Jehovah's Witness.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e449, doi. 10.1111/hae.12992

By:

Chojnowski, K.;
Robak, M.;
Nowak, W.;
Treliński, J.

Publication type:

Article

Adherence to prophylactic treatment in patients with haemophilia in Germany.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e367, doi. 10.1111/hae.13003

By:

Miesbach, W.;
Kalnins, W.

Publication type:

Article

Total joint replacement in haemophilia A patients with high titre of inhibitor using a new brand recombinant factor VIIa (Aryoseven®).

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e451, doi. 10.1111/hae.13006

By:

Mortazavi, S. M. J.;
Najafi, A.;
Toogeh, G.

Publication type:

Article

Joint bleeds increase the inhibitor response to human factor VIII in a rat model of severe haemophilia A.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 772, doi. 10.1111/hae.13014

By:

Lövgren, K. M.;
Søndergaard, H.;
Skov, S.;
Wiinberg, B.

Publication type:

Article

Haemophilia registries to complement clinical trial data: a pious hope or an urgent necessity?

Published in:

2016

By:

Keipert, C.;
Berg, H. M.;
Keller ‐ Stanislawski, B.;
Hilger, A.

Publication type:

Editorial

Use of donated clotting factors for surgeries on haemophilic patients in a resource-constrained country: a kind donor, good outcome, change of practice and future directions.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e453, doi. 10.1111/hae.13017

By:

Poudyal, B. S.;
Shrestha, G. S.;
Tuladhar, S.;
Gyawali, B.;
Sedain, G.;
Battajo, R.;
Maskey, P.;
Paudyal, S.;
Regmi, S.;
RC, D. R.;
Kouides, P.

Publication type:

Article

Practical aspects of psychological support to the patient with haemophilia from diagnosis in infancy through childhood and adolescence.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e349, doi. 10.1111/hae.13018

By:

García ‐ Dasí, M.;
Torres ‐ Ortuño, A.;
Cid ‐ Sabatel, R.;
Barbero, J.

Publication type:

Article

Modelling lifelong effects of different prophylactic treatment strategies for severe haemophilia A.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e375, doi. 10.1111/hae.13019

By:

Fischer, K.;
Lewandowski, D.;
Janssen, M. P.

Publication type:

Article

An institutional pilot study to investigate physical activity patterns in boys with haemophilia.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e383, doi. 10.1111/hae.13021

By:

Bouskill, V.;
Hilliard, P.;
Stephens, S.;
Zhang, C.;
Whitney, K.;
Carcao, M.

Publication type:

Article

Platelet abnormalities in a family with von Willebrand disease type 2B (V1316M) and association with bleeding score.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e455, doi. 10.1111/hae.13026

By:

Guglielmone, H. A.;
Smith, N.;
Minoldo, S.;
Jarchum, G. D.;
White ‐ Adams, T.;
Di Paola, J.

Publication type:

Article

Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e459, doi. 10.1111/hae.13029

By:

Takedani, H.;
Hirose, J.;
Minamoto, F.;
Kubota, M.;
Kinkawa, J.;
Noguchi, M.

Publication type:

Article

Inhibitor development in two cousins receiving full-length factor VIII (FVIII) and FVIII-Fc fusion protein.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e462, doi. 10.1111/hae.13032

By:

Ragni, M. V.;
Alabek, M.;
Malec, L. M.

Publication type:

Article

Activated prothrombin complex concentrate in combination with tranexamic acid: a single centre experience for the treatment of mucosal bleeding and dental extraction in haemophilia patients with inhibitors.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e465, doi. 10.1111/hae.13035

By:

Windyga, J.;
Stefanska ‐ Windyga, E.;
Odnoczko, E.;
Baran, B.;
Czubak, G.

Publication type:

Article

Response to Wiewel-Verschueren S et al.: gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e435, doi. 10.1111/hae.13036

By:

de Raucourt, E.;
Bauduer, F.;
Goudemand, J.

Publication type:

Article

A case of acquired haemophilia A complicated by peritonitis after distal gastrectomy.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e469, doi. 10.1111/hae.13039

By:

Sato, K.;
Tsukada, N.;
Inamura, J.;
Kon, M.;
Ito, S.;
Hirai, K.;
Hosoki, T.

Publication type:

Article

First preclinical support for the 'danger theory' in inhibitor development.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 654, doi. 10.1111/hae.13042

By:

Vulpen, L. F. D.;
Mastbergen, S. C.;
Schutgens, R. E. G.

Publication type:

Article

Successful bleeding control with recombinant porcine factor VIII in reduced loading doses in two patients with acquired haemophilia A and failure of bypassing agent therapy.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e472, doi. 10.1111/hae.13046

By:

Stemberger, M.;
Möhnle, P.;
Tschöp, J.;
Ney, L.;
Spannagl, M.;
Reincke, Martin

Publication type:

Article

Standardizing patient outcomes measurement to improve haemophilia care.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. 651, doi. 10.1111/hae.13072

By:

Srivastava, A.;
Berg, H. M.

Publication type:

Article

Inhibitor development after liver transplantation in congenital factor VII deficiency.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e417, doi. 10.1111/hae.13047

By:

See, W. ‐ S. Q.;
Chang, K. ‐ O;
Cheuk, D. K. ‐ L.;
Leung, Y. ‐ Y. R.;
Chan, G. C. ‐ F.;
Chan, S. ‐ C.;
Ha, S. ‐ Y.

Publication type:

Article

A new parameter in the thrombin generation assay, mean velocity to peak thrombin, reflects factor VIII activity in patients with haemophilia A.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e474, doi. 10.1111/hae.13052

By:

Takeyama, M.;
Nogami, K.;
Shima, M.

Publication type:

Article

Gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review: response to rebuttal.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e436, doi. 10.1111/hae.13053

By:

Wiewel ‐ Verschueren, S.;
Meijer, K.

Publication type:

Article

Three successful deliveries involving a woman with congenital afibrinogenaemia - conventional fibrinogen concentrate infusion vs. 'as required' fibrinogen concentrate infusion based on changes in fibrinogen clearance -.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e478, doi. 10.1111/hae.13054

By:

Oda, T.;
Itoh, H.;
Kawai, K.;
Oda ‐ Kishimoto, A.;
Kobayashi, T.;
Doi, T.;
Uchida, T.;
Kanayama, N.

Publication type:

Article

Psychometric field testing of the HemoLatin-QoL questionnaire.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e390, doi. 10.1111/hae.13055

By:

Remor, E.

Publication type:

Article

Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e423, doi. 10.1111/hae.13051

By:

Eghbali, A.;
Melikof, L.;
Taherahmadi, H.;
Bagheri, B.

Publication type:

Article